Detalhe da pesquisa
1.
A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis.
Nature
; 597(7878): 709-714, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34497421
2.
NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity.
PLoS Biol
; 17(9): e3000451, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31525189
3.
Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation.
Acta Neuropathol
; 142(5): 899-915, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487221
4.
Experimental Autoimmune Encephalomyelitis Potentiates Mouse Mast Cell Protease 4-Dependent Pressor Responses to Centrally or Systemically Administered Big Endothelin-1.
J Pharmacol Exp Ther
; 370(3): 437-446, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248979
5.
Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis.
Mediators Inflamm
; 2016: 9797021, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27610007
6.
The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.
J Neuroinflammation
; 12: 198, 2015 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26521018
7.
A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.
J Nanobiotechnology
; 13: 62, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26415935
8.
Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction.
Nanomedicine
; 11(4): 1003-18, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596076
9.
Cadmium induces reactive oxygen species-dependent apoptosis in MCF-7 human breast cancer cell line.
Toxicol Mech Methods
; 25(1): 48-55, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403798
10.
Serum levels of TGFß, IL-10, IL-17, and IL-23 cytokines in ß-thalassemia major patients: the impact of silymarin therapy.
Immunopharmacol Immunotoxicol
; 36(4): 271-4, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24945737
11.
A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in ß-thalassemia major patients receiving desferrioxamine.
Eur J Haematol
; 90(3): 202-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23278124
12.
Antibodies to interferon beta in patients with multiple sclerosis receiving CinnoVex, rebif, and betaferon.
J Korean Med Sci
; 28(12): 1801-6, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24339712
13.
Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with ß-thalassemia major.
Hemoglobin
; 37(4): 404-10, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23600495
14.
The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.
Neurotherapeutics
; 20(4): 1229-1240, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296356
15.
Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination.
J Clin Invest
; 133(7)2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719741
16.
1Menstruation: a possible independent health promoter, aging and COVID-19.
Caspian J Intern Med
; 13(Suppl 3): 155-160, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35872674
17.
Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis.
Front Mol Neurosci
; 15: 995477, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36407761
18.
Therapeutic potential of silymarin as a natural iron-chelating agent in ß-thalassemia intermedia.
Clin Case Rep
; 10(1): e05293, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106163
19.
Breaking the barriers to remyelination in multiple sclerosis.
Curr Opin Pharmacol
; 63: 102194, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255453
20.
Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice.
J Neuroimmunol
; 367: 577859, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395486